Cooperative Agreement NU2HGH000109

This federal Project Grant award from the National Institutes of Health's John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $962,344 to the Kintampo Health Research Centre (KHRC) in Ghana to strengthen capacity for policy-relevant life course epidemiological research. The award aims to develop a sustainable pipeline of African physician scientists and postdoctoral investigators dedicated to addressing the growing burden of non-communicable...

This federal Cooperative Agreement award of $1,060,000.00 from the Centers for Disease Control and Prevention (CDC) under the "Centers for Disease Control and Prevention Investigations and Technical Assistance" program (CFDA 93.283) is intended to support the "ADVANCING NATIONAL PUBLIC HEALTH INSTITUTES THROUGH THE GLOBAL NETWORK - 2024" initiative. The primary awardee, Emory University, will leverage its expertise in biomedical research, public health, and infectious disease...

This $55,844,955 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program supports a 5-year initiative to significantly reduce preventable deaths of mothers, newborns, and children in Ghana. The project, led by the non-profit organization Project Hope - The People-To-People Health Foundation Inc., will engage Ghana's public, private, and faith-based health system stakeholders to improve access,...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects program (CFDA 93.185) provides $2,361,235 to the Georgia Department of Public Health (GDPH) to enhance the state's capacity to detect, respond to, prevent, and control emerging infectious diseases. The funding will enable GDPH to expand its epidemiologic and laboratory...

The Task Force for Global Health, Inc. was awarded a $2,475,519.00 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The award, with a performance period from August 1, 2024 to July 31, 2029, supports the Task Force's work in enhancing public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases globally. Key activities...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $153,912 to the University of Ghana Medical Centre to conduct research on the pharmacokinetics and pharmacogenomics of dolutegravir-based antiretroviral therapy in young people living with HIV in Ghana. The key objectives of this research project are to: 1) Determine rates of dolutegravir-based antiretroviral therapy...

This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a longitudinal cohort study to examine the impact of early childhood malaria prevention interventions on malaria risk in school-age children in Ghana. The study, titled "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)", will evaluate the epidemiological and...

The Centers for Disease Control and Prevention (CDC) awarded a $3,502,308 Cooperative Agreement under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) to The Task Force for Global Health, Inc. The award, effective August 1, 2024 through July 31, 2029, supports the organization's efforts to strengthen public health infrastructure and service delivery across the United States. Key activities...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under CFDA 93.318, "Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security," provides $957,317.00 to the International Centre for Diarrhoeal Disease Research, Bangladesh (Icddr,B) to advance public health research in Bangladesh. The five-year project, beginning on September 30, 2024, aims to strengthen infectious disease...

This $5,900,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports the National Health Laboratory Service (NHLS), a non-profit organization based in South Africa. The funding will be used to strengthen infectious disease surveillance, laboratory capabilities, and public health research over a 5-year period from September 2024 to September 2029. Key activities include establishing electronic case reporting...